| payload |
{"created_at":"2026-04-19T03:01:53.054 {"created_at":"2026-04-19T03:01:53.054716+00:00","signal_type":"market_headline_delta","source":"market_ingestor","url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOaTFfVnNDaXFCZmFnSEpjQWZNWDdZbFUzaXFLN3h6cnNIYzdzVlJQU2gwc2J0U2d4LUNZZ3dQbVlCZlR5SDVoSnY4Y0tkLWZKQXBlLVlLSnEwV2RBYXVqSjVzdkg0X1NXV1BGWExrQWJZSFN2bG92TVB5SWRXTU1TUUJFeHpwRTlFS2dycUt4a1drdWdNVjl2ZC1RU2o0Vk9JTEdhcDF6ZmtFWS1SZWk3XzVOOTJkUVBGb2dfN25FSQ?oc=5","value":{"fp":"5344b176d08b8689","published_at":"2026-04-19T02:10:54+00:00","source":"AD HOC NEWS","source_domain":"ad-hoc-news.de","source_url":"https://www.ad-hoc-news.de","summary":"","tickers":[],"title":"Green Cross Corp (GC Biopharma) stock (KR7006280002): Why its plasma therapy focus now matters more - AD HOC NEWS","url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOaTFfVnNDaXFCZmFnSEpjQWZNWDdZbFUzaXFLN3h6cnNIYzdzVlJQU2gwc2J0U2d4LUNZZ3dQbVlCZlR5SDVoSnY4Y0tkLWZKQXBlLVlLSnEwV2RBYXVqSjVzdkg0X1NXV1BGWExrQWJZSFN2bG92TVB5SWRXTU1TUUJFeHpwRTlFS2dycUt4a1drdWdNVjl2ZC1RU2o0Vk9JTEdhcDF6ZmtFWS1SZWk3XzVOOTJkUVBGb2dfN25FSQ?oc=5"}}... |